Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially ...

Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

A variety of non-malignant stromal cells present at the complex tumor microenvironment are active players in cancer progression (1). Specifically in solid tumors, tumor associated macrophages (TAMs) ...

Researchers from National Chung Cheng University (CCU) and National Cheng Kung University (NCKU) have identified a previously ...

Researchers determine a complex immune infiltrate pattern based on a newly constructed immune map developed using pancreatic ...

According to a recent study, Taiwanese researchers found that DUSP2 gene deficiency aids cancer cell growth, especially in ...

This will involve moving its first cancer drug into clinical ... “Since the molecule is macrophage targeted, we don’t affect T-cells, which you would do with a normal p38 inhibitor.” ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

Miriam Merad, Mount Sinai, USA, has studied how cells in the immune system affect the body’s ability to fight tumours. Her ...